CORONAVIRUS DISEASE 2019
Clinical trials for CORONAVIRUS DISEASE 2019 explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS DISEASE 2019 trials appear
Sign up with your email to follow new studies for CORONAVIRUS DISEASE 2019, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to tame deadly COVID-19 in hospitalized patients
Disease control CompletedThis study tested whether a weekly injection called leronlimab could help people hospitalized with severe or critical COVID-19. Nearly 500 participants were randomly assigned to receive either the drug or a placebo shot. Researchers measured if the treatment reduced deaths and he…
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Heartburn & arthritis drugs tested as potential COVID-19 fighters
Disease control CompletedThis trial tested whether a combination of two existing drugs (famotidine and celecoxib) could help hospitalized COVID-19 patients recover faster and prevent severe illness in newly infected people. The study was small, with only 4 total participants, and aimed to see if this dru…
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists probe why COVID-19 wipes out key immune cells
Knowledge-focused CompletedThis study aims to understand how the COVID-19 virus causes a dangerous drop in lymphocytes, a type of white blood cell that fights infections. Researchers collected blood samples from 240 adults who either had active COVID-19 or had recently recovered. By analyzing these samples…
Matched conditions: CORONAVIRUS DISEASE 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC